306 related articles for article (PubMed ID: 6150641)
1. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
Jensen RT; Collen MJ; McArthur KE; Howard JM; Maton PN; Cherner JA; Gardner JD
Am J Med; 1984 Nov; 77(5B):90-105. PubMed ID: 6150641
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion.
Collen MJ; Howard JM; McArthur KE; Raufman JP; Cornelius MJ; Ciarleglio CA; Gardner JD; Jensen RT
Ann Intern Med; 1984 Jan; 100(1):52-8. PubMed ID: 6318628
[TBL] [Abstract][Full Text] [Related]
3. Famotidine in the therapy of gastric hypersecretory states.
Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
[TBL] [Abstract][Full Text] [Related]
4. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome.
Raufman JP; Collins SM; Pandol SJ; Korman LY; Collen MJ; Cornelius MJ; Feld MK; McCarthy DM; Gardner JD; Jensen RT
Gastroenterology; 1983 Jan; 84(1):108-13. PubMed ID: 6128284
[TBL] [Abstract][Full Text] [Related]
5. Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states.
Jensen RT; Collen MJ; Pandol SJ; Allende HD; Raufman JP; Bissonnette BM; Duncan WC; Durgin PL; Gillin JC; Gardner JD
N Engl J Med; 1983 Apr; 308(15):883-7. PubMed ID: 6835285
[No Abstract] [Full Text] [Related]
6. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Maton PN; Gardner JD; Jensen RT
Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602
[TBL] [Abstract][Full Text] [Related]
7. Report on the United States experience with cimetidine in Zollinger-Ellision syndrome and other hypersecretory states.
McCarthy DM
Gastroenterology; 1978 Feb; 74(2 Pt 2):453-8. PubMed ID: 620913
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome.
Lamers CB; Festen HP; van Tongeren JH
Am J Gastroenterol; 1978 Sep; 70(3):286-91. PubMed ID: 717379
[TBL] [Abstract][Full Text] [Related]
9. Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion.
Yamaji Y; Omata T; Abe T; Yoshida A; Ueki S; Aita H; Morita H; Chaki K; Segawa Y; Kurimoto T
Arzneimittelforschung; 1991 Sep; 41(9):954-7. PubMed ID: 1796924
[TBL] [Abstract][Full Text] [Related]
10. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
[TBL] [Abstract][Full Text] [Related]
11. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists.
Lambers CB; Lind T; Moberg S; Jansen JB; Olbe L
N Engl J Med; 1984 Mar; 310(12):758-61. PubMed ID: 6142418
[TBL] [Abstract][Full Text] [Related]
12. Ranitidine: a new H2-receptor antagonist.
Berner BD; Conner CS; Sawyer DR; Siepler JK
Clin Pharm; 1982; 1(6):499-509. PubMed ID: 6309467
[TBL] [Abstract][Full Text] [Related]
13. Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill.
More DG; Raper RF; Munro IA; Watson CJ; Boutagy JS; Shenfield GM
Surgery; 1985 Feb; 97(2):215-24. PubMed ID: 3881838
[TBL] [Abstract][Full Text] [Related]
14. Famotidine: effective treatment of Zollinger-Ellison syndrome.
Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole: a new approach to gastric acid suppression.
Buhl K; Clearfield HR
Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
[TBL] [Abstract][Full Text] [Related]
16. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of systemic mastocytosis with histamine H2 receptor antagonists.
Johnson GJ; Silvis SE; Roitman B; Blumenthal M; Gilbert HS
Am J Gastroenterol; 1980 Dec; 74(6):485-9. PubMed ID: 6782861
[TBL] [Abstract][Full Text] [Related]
18. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
[TBL] [Abstract][Full Text] [Related]
19. Comparative study with ranitidine and cimetidine on gastric secretion.
Sewing KF; Billian A; Malchow H
Scand J Gastroenterol Suppl; 1981 Jun; 69():45-9. PubMed ID: 6119782
[TBL] [Abstract][Full Text] [Related]
20. Effects of cimetidine and ranitidine on gastric transmural potential difference and on prolactin secretion in man.
von Kleist D; Gräf KJ; Dougherty FC; Hampel KE
Hepatogastroenterology; 1981 Aug; 28(4):210-2. PubMed ID: 6115806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
